Published 23 hours ago • loading... • Updated 23 hours ago

Former British Prime Minister David Cameron, Medical Leaders and Researchers from around the World Convene in Cleveland to Discuss Drug Development Progress

On May 23, 2025, the Harrington Discovery Institute hosted its twelfth annual scientific symposium in Cleveland, Ohio, attracting researchers and leaders from around the world.
The symposium addressed challenges in developing treatments for Alzheimer's and rare diseases, which often face funding gaps known as the Valley of Death.
Former UK Prime Minister David Cameron, chair of the Oxford-Harrington Rare Disease Centre Advisory Council, spoke at the event promoting their mission to develop breakthrough rare disease therapies.
Harrington Discovery Institute supports 150 Harrington Scholars with 214 drugs in development, including four in Phase 3 trials for heart attacks, Alzheimer's, macular degeneration, and rare cancer; another targets spina bifida.
The symposium highlighted ongoing global collaboration to overcome barriers in drug development, aiming to deliver 40 new rare disease drugs within 10 years and accelerate unmet medical needs.

Insights by Ground AI

Does this summary seem wrong?